Open AccessOutcome of HIV‐Associated Tuberculosis in the Era of Highly Active Antiretroviral Therapy
Author(s) -
Keertan Dheda,
Fiona Lampe,
Margaret Johnson,
Marc Lipman
Publication year - 2004
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/424676
Subject(s) - medicine , tuberculosis , hazard ratio , confidence interval , antiretroviral therapy , human immunodeficiency virus (hiv) , sida , immunology , viral load , viral disease , pathology
The benefit of highly active antiretroviral therapy (HAART) in the treatment of patients coinfected with tuberculosis (TB) and human immunodeficiency virus (HIV) is unclear because of concerns about treatment-related complications.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom